Advertisement

NeuroRX

, Volume 2, Issue 2, pp 304–323 | Cite as

Therapeutic advances in interventional neurology

  • Jawad F. Kirmani
  • Nazli Janjua
  • Ammar Al Kawi
  • Shafiuddin Ahmed
  • Ismail Khatri
  • Ali Ebrahimi
  • Afshin A. Divani
  • Adnan I. Qureshi
Article

Summary

Rapid advances in the field of interventional neurology and the development of minimally invasive techniques have resulted in a great expansion of potential therapeutic applications. We discuss therapeutic interventional neurology as applied in clinical practice in one of the two possible ways: 1) embolization leading to occlusion of blood vessels; and 2) revascularization leading to reopening of blood vessels. These procedures can be applied to a broad range of cerebrovascular diseases. In the first section of this review, we will explore the evolution of these interventions to occlude aneurysms, arteriovenous malformations, neurovascular tumors, and injuries. In the second section, revascularization in acute ischemic stroke, stenosis, and dural venous thrombosis will be discussed.

Key Words

Interventional neuroimaging ischemic stroke intracranial aneurysm cerebral vasospasm arteriovenous malformation cerebral venous thrombosis embolization 

References

  1. 1.
    Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1—Programs and Collection Procedures.Vital Health Stat 1, 32: 1–407, 1994.Google Scholar
  2. 2.
    Detailed diagnosis and procedures, national hospital discharge survey, 1990. Hyattsville, MD: U.S. Department of Health and Human Services. DHHS publication, Series 13, 1992.Google Scholar
  3. 3.
    Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review.Stroke 29: 251–256, 1998.PubMedGoogle Scholar
  4. 4.
    Werner SCBA, King BG. Aneurysm of the internal carotid artery within the skull: wiring and electrothermic coagulation.JAMA 116: 578, 1941.Google Scholar
  5. 5.
    Hopkins LN, Lanzino G, Guterman LR. Treating complex nervous system vascular disorders through a “needle stick”: origins, evolution, and future of neuroendovascular therapy.Neurosurgery 48: 463–475, 2001.PubMedGoogle Scholar
  6. 6.
    Guglielmi G, Vinuela F, Sepetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach. Part 1: electrochemical basis, technique, and experimental results.J Neurosurg 75: 1–7, 1991.PubMedGoogle Scholar
  7. 7.
    Stiver SI, Porter PJ, Willinsky RA, Wallace MC. Acute human histopathology of an intracranial aneurysm treated using guglielmi detachable coils: Case report and review of the literature.Neurosurgery 43: 1203–1208, 1998.PubMedGoogle Scholar
  8. 8.
    Qureshi AI, Suri MF, Khan J, Kim SH, Fessler RD, Ringer AJ, et al. Endovascular treatment of intracranial aneurysms by using guglielmi detachable coils in awake patients: safety and feasibility.J Neurosurg 94: 880–885, 2001.PubMedGoogle Scholar
  9. 9.
    Mawad ME, Cekirge S, Ciceri E, Saatci I. Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection.J Neurosurg 96: 474–482, 2002.PubMedGoogle Scholar
  10. 10.
    Sedat J, Dib M, Lonjon M, Litrico S, Von Langsdorf D, Fontaine D, Paquis P. Endovascular treatment of ruptured intracranial aneurysms in patients aged 65 years and older: follow-up of 52 patients after 1 year.Stroke 33: 2620–2625, 2002.PubMedGoogle Scholar
  11. 11.
    Kremer C, Groden C, Hansen HC, Grzyska U, Zeumer H. Outcome after endovascular treatment of hunt and hess grade IV or V aneurysms: comparison of anterior versus posterior circulation.Stroke 30: 2617–2622, 1999.PubMedGoogle Scholar
  12. 12.
    Vallee JN, Aymard A, Vicaut E, Reis M, Merland JJ. Endovascular treatment of basilar tip aneurysms with guglielmi detachable coils: predictors of immediate and long-term results with multi-variate analysis 6-year experience.Radiology 226: 867–879, 2003.PubMedGoogle Scholar
  13. 13.
    Baltsavias GS, Byrne JV, Halsey J, Coley SC, Sohn MJ, Molyneux AJ. Effects of timing of coil embolization after aneurysmal subarachnoid hemorrhage on procedural morbidity and outcomes.Neurosurgery 47: 1320–1329, 2000.PubMedGoogle Scholar
  14. 14.
    Morizane A, Nakahara I, Sakai N, Yanamoto H, Akiyama Y, Sakai H, et al. Endovascular surgery for untreated ruptured aneurysm with symptomatic vasospasm.No Shinkei Geka 27: 941–946, 1999.PubMedGoogle Scholar
  15. 15.
    Johnston SC, Higashida RT, Barrow DL, Caplan LR, Dion JE, Hademenos G, et al. Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology.Stroke 33: 2536–2544, 2002.PubMedGoogle Scholar
  16. 16.
    Vanninen R, Koivisto T, Saari T, Hernesniemi J, Vapalahti M. Ruptured intracranial aneurysms: acute endovascular treatment with electrolytically detachable coils—a prospective randomized study.Radiology 211: 325–336, 1999.PubMedGoogle Scholar
  17. 17.
    Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.Lancet 360: 1267–1274, 2002.PubMedGoogle Scholar
  18. 18.
    Johnston SC, Dudley RA, Gress DR, Ono L. Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals.Neurology 52: 1799–1805, 1999.PubMedGoogle Scholar
  19. 19.
    Moret J, Cognard C, Weill A, Castaings L, Rey A. [Reconstruction technic in the treatment of wide-neck intracranial aneurysms. Long-term angiographic and clinical results. Apropos of 56 cases].J Neuroradiol 24: 30–44, 1997.PubMedGoogle Scholar
  20. 20.
    Wallace RC, Flom RA, Khayata MH, Dean BL, McKenzie J, Rand JC, et al. The safety and effectiveness of brain arteriovenous malformation embolization using acrylic and particles: the experiences of a single institution.Neurosurgery 37: 606–615, 1995.PubMedGoogle Scholar
  21. 21.
    Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment.J Neurosurg 73: 387–391, 1990.PubMedGoogle Scholar
  22. 22.
    Vinuela F, Dion JE, Duckwiler G, Martin NA, Lylyk P, Fox A, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases.J Neurosurg 75: 856–864, 1991.PubMedGoogle Scholar
  23. 23.
    Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R, et al. AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the stroke council, American stroke association.Stroke 32: 1458–1471, 2001.PubMedGoogle Scholar
  24. 24.
    Sisti MB, Kader A, Stein BM. Microsurgery for 67 intracranial arteriovenous malformations less than 3 cm in diameter.J Neurosurg 79: 653–660, 1993.PubMedGoogle Scholar
  25. 25.
    Purdy PD, Batjer HH, Risser RC, Samson D. Arteriovenous malformations of the brain: choosing embolic materials to enhance safety and ease of excision.J Neurosurg 77: 217–222, 1992.PubMedGoogle Scholar
  26. 26.
    Flickinger JC, Pollock BE, Kondziolka D, Lunsford LD. A dose-response analysis of arteriovenous malformation obliteration after radiosurgery.Int J Radiat Oncol Biol Phys 36: 873–879, 1996.PubMedGoogle Scholar
  27. 27.
    Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ. The effect of embolization with n-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations.J Neurosurg 78: 60–69, 1993.PubMedGoogle Scholar
  28. 28.
    N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.AJNR Am J Neuroradiol 23:748-755, 2002.Google Scholar
  29. 29.
    Gobin YP, Laurent A, Merienne L, Schlienger M, Aymard A, Houdart E, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery.J Neurosurg 85: 19–28, 1996.PubMedGoogle Scholar
  30. 30.
    Roy D, Raymond J. The role of transvenous embolization in the treatment of intracranial dural arteriovenous fistulas.Neurosurgery 40: 1133–1141, 1997.PubMedGoogle Scholar
  31. 31.
    Murphy KJ, Gailloud P, Venbrux A, Deramond H, Hanley D, Rigamonti D. Endovascular treatment of a grade IV transverse sinus dural arteriovenous fistula by sinus recanalization, angio-plasty, and stent placement: technical case report.Neurosurgery 46: 497–500, 2000.PubMedGoogle Scholar
  32. 32.
    Vinuela FV, Debrun GM, Fox AJ, Girvin JP, Peerless SJ. Dominant-hemisphere arteriovenous malformations: therapeutic embolization with isobutyl-2-cyanoacrylate.AJNR Am J Neuroradiol 4: 959–966, 1983.PubMedGoogle Scholar
  33. 33.
    Nicholson AA. Vascular radiology in trauma.Cardiovasc Intervent Radiol 27: 105–120, 2004.PubMedGoogle Scholar
  34. 34.
    McArthur CS, Marin ML. Endovascular therapy for the treatment of arterial trauma.Mt Sinai J Med 71: 4–11, 2004.PubMedGoogle Scholar
  35. 35.
    Stockinger ZT, Townsend MC, McSwain NE Jr, Hewitt RL. Acute endovascular management of a subclavian artery injury.J LA State Med Soc 156: 262–264, 2004.PubMedGoogle Scholar
  36. 36.
    Assadian A, Senekowitsch C, Rotter R, Zolss C, Strassegger J, Hagmuller GW. Long-term results of covered stent repair of internal carotid artery dissections.J Vasc Surg 40: 484–487, 2004.PubMedGoogle Scholar
  37. 37.
    Luo CB, Teng MM, Chang FC, Lirng JF, Chang CY. Endovascular management of the traumatic cerebral aneurysms associated with traumatic carotid cavernous fistulas.AJNR Am J Neuroradiol 25: 501–505, 2004.PubMedGoogle Scholar
  38. 38.
    Liu JK, Decker D, Tenner MS, Couldwell WT, Chiles BW 3rd. Traumatic arteriovenous fistula of the posterior inferior cerebellar artery treated with endovascular coil embolization: case report.Surg Neurol 61: 255–260, 2004.PubMedGoogle Scholar
  39. 39.
    Lee CY, Yim MB, Kim IM, Son EI, Kim DW. Traumatic aneurysm of the supraclinoid internal carotid artery and an associated carotid-cavernous fistula: Vascular reconstruction performed using intravascular implantation of stents and coils. Case report.J Neurosurg 100: 115–119, 2004.PubMedGoogle Scholar
  40. 40.
    Klisch J, Huppertz HJ, Spetzger U, Hetzel A, Seeger W, Schumacher M. Transvenous treatment of carotid cavernous and dural arteriovenous fistulae: results for 31 patients and review of the literature.Neurosurgery 53: 836–856, 2003.PubMedGoogle Scholar
  41. 41.
    Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.J Neurosurg 76: 772–781, 1992.PubMedGoogle Scholar
  42. 42.
    Qureshi AI. Endovascular treatment of cerebrovascular diseases and intracranial neoplasms.Lancet 363: 804–813, 2004.PubMedGoogle Scholar
  43. 43.
    Alexander LF, Ward BA. The history of endovascular therapy.Neurosurg Clin N Am 5: 383–391, 1994.PubMedGoogle Scholar
  44. 44.
    Hekster RE, Luyendijk W, Tan TI. Spinal-cord compression caused by vertebral haemangioma relieved by percutaneous catheter embolisation.Neuroradiology 3: 160–164, 1972.PubMedGoogle Scholar
  45. 45.
    Ahuja A, Gibbons KJ. Endovascular therapy of central nervous system tumors.Neurosurg Clin N Am 5: 541–554, 1994.PubMedGoogle Scholar
  46. 46.
    Pandya SK, Nagpal RD. External carotid embolisation—an useful prior adjunct to excision of convexity cerebral meningiomas.Neurol India 24: 182–184, 1976.PubMedGoogle Scholar
  47. 47.
    Head, neck, and brain tumor embolization.AJNR Am J Neuroradiol 22:S14–S15, 2001.Google Scholar
  48. 48.
    Bendszus M, Martin-Schrader I, Schlake HP, Solymosi L. Embolisation of intracranial meningiomas without subsequent surgery.Neuroradiology 45: 451–455, 2003.PubMedGoogle Scholar
  49. 49.
    Brismar J, Cronqvist S. Therapeutic embolization in the external carotid artery region.Acta Radiol Diagn (Stockh) 19: 715–731, 1978.Google Scholar
  50. 50.
    Richter HP, Schachenmayr W. Preoperative embolization of intracranial meningiomas.Neurosurgery 13: 261–268, 1983.PubMedGoogle Scholar
  51. 51.
    Manelfe C, Guiraud B, David J, Eymeri JC, Tremoulet M, Espagno J, et al. [Embolization by catheterization of intracranial meningiomas].Rev Neurol (Paris) 128: 339–351, 1973.Google Scholar
  52. 52.
    Jungling FD, Wakhloo AK, Hennig J. In vivo proton spectroscopy of meningioma after preoperative embolization.Magn Reson Med 30: 155–160, 1993.PubMedGoogle Scholar
  53. 53.
    Khayatya MDB, Flom RA. Efficacy of endovascular treatment of meningiomas: a controlled study.J Neurosurg 78: 346A, 1993.Google Scholar
  54. 54.
    Cloughesy TF, Gobin YP, Black KL, Vinuela F, Taft F, Kadkhoda B, et al. Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow.J Neurooncol 35: 121–131, 1997.PubMedGoogle Scholar
  55. 55.
    Inamura T, Nomura T, Bartus RT, Black KL. Intracarotid infusion of rmp-7, a bradykinin analog: a method for selective drug delivery to brain tumors.J Neurosurg 81: 752–758, 1994.PubMedGoogle Scholar
  56. 56.
    Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.Lancet 352: 1245–1251, 1998.PubMedGoogle Scholar
  57. 57.
    Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke RT-PA stroke study group.N Engl J Med 333: 1581–1587, 1995.Google Scholar
  58. 58.
    Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) Study.JAMA 283: 1145–1150, 2000.PubMedGoogle Scholar
  59. 59.
    Qureshi AI. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke.Neurosurgery 50: 1405–1414, 2002.PubMedGoogle Scholar
  60. 60.
    Qureshi AI, Ringer AJ, Suri MF, Guterman LR, Hopkins LN. Acute interventions for ischemic stroke: present status and future directions.J Endovasc Ther 7: 423–428, 2000.PubMedGoogle Scholar
  61. 61.
    Qureshi AI, Pande RU, Kim SH, Hanel RA, Kirmani JF, Yahia AM. Third generation thrombolytics for the treatment of ischemic stroke.Curr Opin Investig Drugs 3: 1729–1732, 2002.PubMedGoogle Scholar
  62. 62.
    Qureshi AI, Siddiqui AM, Suri MF, Kim SH, Ali Z, Yahia AM, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study.Neurosurgery 51: 1319–1327, 2002.PubMedGoogle Scholar
  63. 63.
    Boulos AS, Levy EI, Bendok BR, Kim SH, Qureshi AI, Guterman LR, et al. Evolution of neuroendovascular intervention: a review of advancement in device technology.Neurosurgery 54: 438–452, 2004.PubMedGoogle Scholar
  64. 64.
    del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism.Stroke 29: 4–11, 1998.PubMedGoogle Scholar
  65. 65.
    Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism.JAMA 282: 2003–2011, 1999.PubMedGoogle Scholar
  66. 66.
    Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, et al. Combined intravenous and intra-arterial r-tPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial.Stroke 30: 2598–2605, 1999.PubMedGoogle Scholar
  67. 67.
    Mahon BR, Nesbit GM, Barnwell SL, Clark W, Marotta TR, Weill A, Teal PA, Qureshi AI. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke.AJNR Am J Neuroradiol 24: 534–538, 2003.PubMedGoogle Scholar
  68. 68.
    Bellon RJ, Putman CM, Budzik RF, Pergolizzi RS, Reinking GF, Norbash AM. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke.AJNR Am J Neuroradiol 22: 526–530, 2001.PubMedGoogle Scholar
  69. 69.
    Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R, et al. Merci 1: a phase 1 study of mechanical embolus removal in cerebral ischemia.Stroke 35: 2848–2854, 2004.PubMedGoogle Scholar
  70. 70.
    Goose Neck snares. Available at: http://www.Microvena.Com/. Accessed December 29, 2004.Google Scholar
  71. 71.
    Kerber CW, Ban- JD, Berger RM, Chopko BW. Snare retrieval of intracranial thrombus in patients with acute stroke.J Vasc Interv Radiol 13: 1269–1274, 2002.PubMedGoogle Scholar
  72. 72.
    Edna Robertson HN, David M. History Dentistry Research Group. A composition on ‘stents’ available [online] at http:// www.rcpsglasg.ac.uk/hdrg/2003oct8.htm. Accessed December 29, 2004.Google Scholar
  73. 73.
    Yahia AM QA, Boulos AS, Kirmani JF, Kim SH, Siddiqui AM, Hopkins LN. Balloon expandable stents for intracranial arterial occlusion in patients with ischemic stroke. Paper presented at the 7th International Symposium on Thrombolysis and Acute Stroke Therapy, Lyon, France, May 27–29, 2002.Google Scholar
  74. 74.
    Kim SH, Qureshi AI, Levy EI, Hanel RA, Siddiqui AM, Hopkins LN. Emergency stent placement for symptomatic acute carotid artery occlusion after endarterectomy. Case report.J Neurosurg 101: 151–153, 2004.PubMedGoogle Scholar
  75. 75.
    Gershlick AH. Role of stenting in coronary revascularisation.Heart 86: 104–112, 2001.PubMedGoogle Scholar
  76. 76.
    King SB 3rd, Schlumpf M. Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience.J Am Coll Cardiol 22: 353–360, 1993.PubMedGoogle Scholar
  77. 77.
    Halloran PF. Sirolimus and cyclosporin for renal transplantation.Lancet 356: 179–180, 2000.PubMedGoogle Scholar
  78. 78.
    Zohlnhofer D, Klein CA, Richter T, Brandl R, Murr A, Nuhrenberg T, et al. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation.Circulation 103: 1396–1402, 2001.PubMedGoogle Scholar
  79. 79.
    Cohen DJ, Ramee S, Baim DS, Sharma S, Carrozza JP, Cosgrove R, et al. Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: results from a randomized clinical trial.Am Heart J 142: 648–656, 2001.PubMedGoogle Scholar
  80. 80.
    Silva JA, Ramee SR, Cohen DJ, Carrozza JP, Popma JJ, Lansky AA, et al. Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the Angiojet catheter.Am Heart J 41: 353–359, 2001.Google Scholar
  81. 81.
    Broderick JP, Hacke W. Treatment of acute ischemic stroke. Part I: recanalization strategies.Circulation 106: 1563–1569, 2002.PubMedGoogle Scholar
  82. 82.
    Berlis A, Lutsep H, Barnwell S, Norbash A, Wechsler L, Jungreis CA, et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization.Stroke 35: 1112–1116, 2004.PubMedGoogle Scholar
  83. 83.
    North American Symptomatic Carotid Endarterectomy Trial collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.N Engl J Med 325: 445–453, 1991.Google Scholar
  84. 84.
    Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators.N Engl J Med 339: 1415–1425, 1998.PubMedGoogle Scholar
  85. 85.
    Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST).Lancet 351: 1379–1387, 1998.Google Scholar
  86. 86.
    Endarterectomy for asymptomatic carotid artery stenosis. Executive committee for the asymptomatic carotid atherosclerosis study.JAMA 273: 1421–1428, 1995.Google Scholar
  87. 87.
    Stukenborg GJ. Comparison of carotid endarterectomy outcomes from randomized controlled trials and Medicare administrative databases.Arch Neurol 54: 826–832, 1997.PubMedGoogle Scholar
  88. 88.
    Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the medicare population: trial hospitals, volume, and patient characteristics.JAMA 279: 1278–1281, 1998.PubMedGoogle Scholar
  89. 89.
    Goldstein LB, McCrory DC, Landsman PB, Samsa GP, Ancukiewicz M, Oddone EZ, Matchar DB. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms.Stroke 25: 1116–1121, 1994.PubMedGoogle Scholar
  90. 90.
    Goldstein LB, Samsa GP, Matchar DB, Oddone EZ. Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis.Stroke 29: 750–753, 1998.PubMedGoogle Scholar
  91. 91.
    Rothwell PM, Slattery J, Warlow CP. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review.BMJ 315: 1571–1577, 1997.PubMedGoogle Scholar
  92. 92.
    Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application.Circulation 30: 654–670, 1964.PubMedGoogle Scholar
  93. 93.
    Gruntzig A, Kumpe DA. Technique of percutaneous transluminal angioplasty with the gruntzig ballon catheter.AJR Am J Roentgenol 132: 547–552, 1979.PubMedGoogle Scholar
  94. 94.
    Mullan S, Duda EE, Patronas NJ. Some examples of balloon technology in neurosurgery.J Neurosurg 52: 321–329, 1980.PubMedGoogle Scholar
  95. 95.
    Hanel RA, Xavier AR, Kirmani JF, Yahia AM, Qureshi AI. Management of carotid artery stenosis: comparing endarterectomy and stenting.Curr Cardiol Rep 5: 153–159, 2003.PubMedGoogle Scholar
  96. 96.
    Yadav I. Stenting and angioplasty with protection in patients at high risk for endarterectomy. Paper presented at the 15th Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington, DC, pp 153–159, September 15–17, 2003.Google Scholar
  97. 97.
    Archer T. Acculink for revascularization of carotid in high-risk patients. Paper presented at the American College of Cardiology 52nd Second Annual Meeting Scientific Session, Chicago, IL, March 29–April 2, 2003.Google Scholar
  98. 98.
    Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomised trial.Lancet 357: 1729–1737, 2001.Google Scholar
  99. 99.
    Hobson R. Carotid Revascularization Endarterectomy Versus Stent Trial (CREST).Stroke 34: 238, 2003.Google Scholar
  100. 100.
    Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures. Part II—clinical aspects and recommendations.Neurosurgery 46: 1360–1375, 2000.PubMedGoogle Scholar
  101. 101.
    Mukherjee D, Kalahasti V, Roffi M, Bhatt DL, Kapadia SR, Bajzer C, et al. Self-expanding stents for carotid interventions: comparison of nitinol versus stainless-steel stents.J Invasive Cardiol 13: 732–735, 2001.PubMedGoogle Scholar
  102. 102.
    Qureshi AI, Ziai WC, Yahia AM, Mohammad Y, Sen S, Agarwal P, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study.Neurosurgery 52: 1033–1039, 2003.PubMedGoogle Scholar
  103. 103.
    Hofmann R, Kerschner K, Steinwender C, Kypta A, Bibl D, Leisch F. Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: a randomized study.Stroke 33: 725–727, 2002.PubMedGoogle Scholar
  104. 104.
    Markus HS, Clifton A, Buckenham T, Brown MM. Carotid angioplasty. Detection of embolic signals during and after the procedure.Stroke 25: 2403–2406, 1994.PubMedGoogle Scholar
  105. 105.
    McCleary AJ, Nelson M, Dearden NM, Calvey TA, Gough MJ. Cerebral haemodynamics and embolization during carotid angioplasty in high-risk patients.Br J Surg 85: 771–774, 1998.PubMedGoogle Scholar
  106. 106.
    Grube E, Colombo A, Hauptmann E, Londero H, Reifart N, Gerckens U, et al. Initial multicenter experience with a novel distal protection filter during carotid artery stent implantation.Catheter Cardiovasc Intent 58: 139–146, 2003.Google Scholar
  107. 107.
    van Heesewijk HP, Vos JA, Louwerse ES, Van Den Berg JC, Overtoom TT, Ernst SM, Mauser HW, et al. New brain lesions at MR imaging after carotid angioplasty and stent placement.Radiology 224: 361–365, 2002.PubMedGoogle Scholar
  108. 108.
    Barth A, Remonda L, Lovblad KO, Schroth G, Seiler RW. Silent cerebral ischemia detected by diffusion-weighted MRI after carotid endarterectomy.Stroke 31: 1824–1828, 2000.PubMedGoogle Scholar
  109. 109.
    Theron J. The techniques for distal protection during CAS.Radiology 201: 627–636, 1966.Google Scholar
  110. 110.
    Adami CA, Scuro A, Spinamano L, Galvagni E, Antoniucci D, Farello GA, et al. Use of the parodi anti-embolism system in carotid stenting: Italian trial results.J Endovasc Ther 9: 147–154, 2002.PubMedGoogle Scholar
  111. 111.
    Whitlow PL, Lylyk P, Londero H, Mendiz OA, Mathias K, Jaeger H, Parodi J, Schonholz C, Milei J. Carotid artery stenting protected with an emboli containment system.Stroke 33: 1308–1314, 2002.PubMedGoogle Scholar
  112. 112.
    Reimers B, Corvaja N, Moshiri S, Sacca S, Albiero R, Di Mario C, Pascotto P, Colombo A. Cerebral protection with filter devices during carotid artery stenting.Circulation 104: 12–15, 2001.PubMedGoogle Scholar
  113. 113.
    Mubarak N. Multicenter evalution of carotid artery stenting with a filter protection system.J Am Coll Cardiol 39, 2002.Google Scholar
  114. 114.
    Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis.Stroke 27: 1974–1980, 1996.PubMedGoogle Scholar
  115. 115.
    Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery.Stroke 17: 1112–1120, 1986.PubMedGoogle Scholar
  116. 116.
    Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, et al. The warfarin-aspirin symptomatic intracranial disease study.Neurology 45: 1488–1493, 1995.PubMedGoogle Scholar
  117. 117.
    Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: Outcome of patients who fail antithrombotic therapy.Neurology 55: 490–497, 2000.PubMedGoogle Scholar
  118. 118.
    Kirmani JF, Hassan A, Ahmed S, Chowdhury F, Rahman A, Pullicino P. A comparative prospective evaluation of stenoocclusive disease in patients with ischemic stroke using magnetic resonance angiography and digital subtraction angiography. Paper presented at the 27th Annual Meeting of the American Society of Neuroimaging, Phoenix, AZ, January 28–31, 2004.Google Scholar
  119. 119.
    Qureshi AI, Suri MF, Ali Z, Kim SH, Fessler RD, Ringer AJ, et al. Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice.Stroke 32: 2287–2291, 2001.PubMedGoogle Scholar
  120. 120.
    Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results.Stroke 35:1388-1392, 2004Google Scholar
  121. 121.
    Ali Z. Single center stidy to evaluate long-term effectiveness of angioplasty and/or stent placement for intracranial atherosclerotic disease.Neurology 58: A313, 2002.Google Scholar
  122. 122.
    Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis.Stroke 30: 1065–1069, 1999.PubMedGoogle Scholar
  123. 123.
    Gomez CR, Misra VK, Liu MW, Wadlington VR, Terry JB, Tulyapronchote R, et al. Elective stenting of symptomatic basilar artery stenosis.Stroke 31: 95–99, 2000.PubMedGoogle Scholar
  124. 124.
    Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: Drug-eluting stents: part I.Circulation 107: 2274–2279, 2003.PubMedGoogle Scholar
  125. 125.
    Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: Drug-eluting stents: part II.Circulation 107: 2383–2389, 2003.PubMedGoogle Scholar
  126. 126.
    Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.Circulation 107: 24–27, 2003.PubMedGoogle Scholar
  127. 127.
    Lemos PA, Lee CH, Degertekin M, Saia F, Tanabe K, Arampatzis CA, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (research) registry.J Am Coll Cardiol 41: 2093–2099, 2003.PubMedGoogle Scholar
  128. 128.
    Bousser MG. Cerebral venous thrombosis: diagnosis and management.J Neurol 247: 252–258, 2000.PubMedGoogle Scholar
  129. 129.
    Bakshi R, Lindsay BD, Bates VE, et al. Cerebral venous infarctions presenting as enhancing space-occupying lesions: MRI findings.J Neuroimaging 8: 210–215, 1998.PubMedGoogle Scholar
  130. 130.
    Wasay M, Bakshi R, Kojan S, et al. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis.Stroke 32: 2310–2317, 2001.PubMedGoogle Scholar
  131. 131.
    de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.Stroke 30: 484–488, 1999.PubMedGoogle Scholar
  132. 132.
    Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients.Stroke 27: 243–246, 1996.PubMedGoogle Scholar
  133. 133.
    Smith AG, Cornblath WT, Deveikis JP. Local thrombolytic therapy in deep cerebral venous thrombosis.Neurology 48: 1613–1619, 1997.PubMedGoogle Scholar
  134. 134.
    Fink JN, McAuley DL. Safety of anticoagulation for cerebral venous thrombosis associated with intracerebral hematoma.Neurology 57: 1138–1139, 2001.PubMedGoogle Scholar
  135. 135.
    Wasay M, Bakshi R, Suleman K, Bobustuc G, Dubey N. Superior sagittal sinus thrombosis due to lithium: local urokinase thrombolysis treatment.Neurology 54: 532–533, 2000.PubMedGoogle Scholar
  136. 136.
    Frey JL, Muro GJ, McDougall CG, Dean BL, Jahnke HK. Cerebral venous thrombosis: combined intrathrombus rtPA and intravenous heparin.Stroke 30: 489–494, 1999.PubMedGoogle Scholar
  137. 137.
    Horowitz M, Purdy P, Unwin H, Carstens G 3rd, Greenlee R, Hise J, et al. Treatment of dural sinus thrombosis using selective catheterization and urokinase.Ann Neurol 38: 58–67, 1995.PubMedGoogle Scholar
  138. 138.
    Chaloupka JC, Mangla S, Huddle DC. Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: case presentation and technical report.Neurosurgery 45: 650–656, 1999.PubMedGoogle Scholar
  139. 139.
    Malek AM, Higashida RT, Balousek PA, Phatouros CC, Smith WS, Dowd CF, et al. Endovascular recanalization with balloon angioplasty and stenting of an occluded occipital sinus for treatment of intracranial venous hypertension: technical case report.Neurosurgery 44: 896–901, 1999.PubMedGoogle Scholar
  140. 140.
    Baker MD, Opatowsky MJ, Wilson JA, Glazier SS, Morris PP. Rheolytic catheter and thrombolysis of dural venous sinus thrombosis: a case series.Neurosurgery 48: 487–493, 2001.PubMedGoogle Scholar
  141. 141.
    Choi IS, Tantivatana J. Neuroendovascular management of intracranial and spinal tumors.Neurosurg Clin N Am 11: 167–185, 2000.PubMedGoogle Scholar
  142. 142.
    Standard LH. Principals of neuroendovascular intervention. Chicago, IL: American Association of Neurological Surgeons, 1995.Google Scholar
  143. 143.
    Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, et al. Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage.N Engl J Med 308: 619–624, 1983.PubMedGoogle Scholar
  144. 144.
    Haley EC Jr, Kassell NF, Torner JC. The international cooperative study on the timing of aneurysm surgery. The North American experience.Stroke 23: 205–214, 1992.PubMedGoogle Scholar
  145. 145.
    Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington.Neurology 43: 712–718, 1993.PubMedGoogle Scholar
  146. 146.
    Yamamoto Y, Smith RR, Bernanke DH. Mechanism of action of balloon angioplasty in cerebral vasospasm.Neurosurgery 30: 1–5, 1992.PubMedGoogle Scholar
  147. 147.
    Higashida RT, Halbach VV, Cahan LD, Brant-Zawadzki M, Barnwell S, Dowd C, et al. Transluminal angioplasty for treatment of intracranial arterial vasospasm.J Neurosurg 71: 648–653, 1989.PubMedGoogle Scholar
  148. 148.
    Milbum JM, Moran CJ, Cross DT 3rd, Diringer MN, Pilgram TK, Dacey RG Jr. Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration.J Neurosurg 88: 38–42, 1998.Google Scholar
  149. 149.
    Hanel RA, Xavier AR, Mohammad Y, Kirmani JF, Yahia AM, Qureshi AI. Outcome following intracerebral hemorrhage and subarachnoid hemorrhage.Neurol Res 24(Suppl 1): S58-S62, 2002.PubMedGoogle Scholar
  150. 150.
    Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF. Intra-arterial papaverine-induced seizures: case report and review of the literature.Surg Neurol 56: 159–163, 2001.PubMedGoogle Scholar
  151. 151.
    Qureshi AI, Frankel MR. Recognition and management of subarachnoid hemorrhage.Heart Dis Stroke 3: 270–274, 1994.PubMedGoogle Scholar
  152. 152.
    Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA. Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.Crit Care Med 28: 984–990, 2000.PubMedGoogle Scholar
  153. 153.
    J Wada RT. Intracarotid injection of sodium amobarbital for the lateralization of cerebral speech dominance.J Neurosurg 17: 226, 1960.Google Scholar
  154. 154.
    Trenerry MR. Neuropsychologic assessment in surgical treatment of epilepsy.Mayo Clin Proc 71: 1196–1200, 1996.PubMedGoogle Scholar
  155. 155.
    Trenerry MR, Loring DW. Intracarotid amobarbital procedure. The Wada test.Neuroimaging Clin N Am 5: 721–728, 1995.PubMedGoogle Scholar
  156. 156.
    Barr JD, Mathis JM, Horton JA. Provocative pharmacologic testing during arterial embolization.Neurosurg Clin N Am 5: 403–411, 1994.PubMedGoogle Scholar
  157. 157.
    Brassel F, Weissenborn K, Ruckert N, Hussein S, Becker H. Superselective intra-arterial amytal (Wada test) in temporal lobe epilepsy: basics for neuroradiological investigations.Neuroradiology 38: 417–421, 1996.PubMedGoogle Scholar
  158. 158.
    Jack CR Jr, Nichols DA, Sharbrough FW, Marsh WR, Petersen RC. Selective posterior cerebral artery amytal test for evaluating memory function before surgery for temporal lobe seizure.Radiology 168: 787–793, 1988.PubMedGoogle Scholar
  159. 159.
    Jack CR Jr, Nichols DA, Shaibrough FW, Marsh WR, Petersen RC, et al. Selective posterior cerebral artery injection of amytal: new method of preoperative memory testing.Mayo Clin Proc 64: 965–975, 1989.PubMedGoogle Scholar
  160. 160.
    Urbach H, Klemm E, Linke DB, Behrends K, Biersack HJ, Schramm J, et al. Posterior cerebral artery Wada test: sodium amytal distribution and functional deficits.Neuroradiology 43: 290–294, 2001.PubMedGoogle Scholar
  161. 161.
    Fitzsimmons BF, Marshall RS, Pile-Spellman J, Lazar RM. Neurobehavioral differences in superselective Wada testing with amobarbital versus lidocaine.AJNR Am J Neuroradiol 24: 1456–1460, 2003.PubMedGoogle Scholar

Copyright information

© The American Society for Experimental NeuroTherapeutics, Inc 2005

Authors and Affiliations

  • Jawad F. Kirmani
    • 1
    • 2
  • Nazli Janjua
    • 1
  • Ammar Al Kawi
    • 1
  • Shafiuddin Ahmed
    • 1
  • Ismail Khatri
    • 1
  • Ali Ebrahimi
    • 1
  • Afshin A. Divani
    • 1
  • Adnan I. Qureshi
    • 1
  1. 1.Zeenat Qureshi Stroke Research Center, Department of Neurology and NeurosciencesUniversity of Medicine and Dentistry of New JerseyNewark
  2. 2.Doctor’s Office Center 8100Newark

Personalised recommendations